Search
Search Results
##search.searchResults.foundPlural##
-
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1691Suppl. Files: 837HTML: 405PDF: 710 -
-
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1896PDF: 777HTML: 206 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2750PDF: 1093HTML: 11207 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3678PDF: 1530HTML: 8009Randi Fig: 163 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2171PDF: 923HTML: 6769Figure 1: 158 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1348PDF: 801HTML: 3104 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6206PDF: 2057HTML: 13977Untitled: 185figure: 167 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1267PDF: 783HTML: 116 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3154PDF: 978HTML: 1992 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
941PDF: 512HTML: 7799 -
-
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
1736PDF: 863Html: 286 -
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5075PDF: 1296HTML: 2728Cover letter: 179 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3220PDF: 1923HTML: 7456 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1163PDF: 691HTML: 1208 -
-
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3109PDF: 1105HTML: 1461Untitled: 163Untitled: 149Untitled: 155 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2273PDF: 946HTML: 7606Untitled: 258Fig2: 168Fig3: 151Fig4: 166 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2007PDF: 1614HTML: 347 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3053PDF: 1122HTML: 373 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4370PDF: 1878HTML: 17712 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1710PDF: 941HTML: 127 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2528PDF: 844HTML: 17447Fig1 Caligaris: 150Fig.2 Caliga: 180 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1331PDF: 862HTML: 1768 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
984PDF: 1097Suppl. Files: 554HTML: 73 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3661PDF: 1059HTML: 2266Figure 1: 198 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3463PDF: 2356HTML: 1416 -
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1155PDF: 566HTML: 203 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1909PDF: 845HTML: 1313 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2046PDF: 946HTML: 131Suppl. Files: 500 -
-
-
-
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2836PDF: 1321HTML: 3552Untitled: 179Untitled: 188Untitled: 167 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2449PDF: 822HTML: 8793Efremov 1: 208Efremov 2: 170 -
IMMUNOLOGY OF TUBERCULOSIS
5158PDF: 1969HTML: 7254Untitled: 188 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3320PDF: 1254HTML: 2196Fi.1 Gritti.Rambaldi: 192 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3260PDF: 1214HTML: 2179 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1213PDF: 457HTML: 18547Figure 1: 154Figure 2: 138Figure 3: 156Figure 4: 188Figure 5: 160







